Skip to content

GORE VIABAHN VBX Balloon Expandable Endo BXB063902ARecalls & reported problems

W. L. Gore & Associates, Inc. · BX2 HEP REDUCED PROFILE BX2 6MMX39MM 6Fr 135CM Cath · Class 3 · Implant

All models of GORE VIABAHN VBX Balloon Expandable Endo (111)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
4
Deaths reported
0
Injuries reported
3
Recalls naming it
1

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00733132658442), received between Jan 16, 2025 and Jun 17, 2026 — classified as 3 injuries, 1 malfunction.

The most frequently reported specific device problem is “Device Dislodged or Dislocated” (1 report).

1 FDA recall record name this device's identifier, 1 still open.

1 other recall cover devices cleared under the same FDA submission (P160021); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 1 reportsFeb 2025: 0 reportsMar 2025: 1 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 1 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 1 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Recalls naming this device

  1. Jul 1, 2024Class IIOpen, Classified

    Due to packaging defects, sterility assurance and heparin activity may be compromised.

    Z-2945-2024 · Root cause: Package design/selection · Recall details · FDA record ↗

Most reported problems

Device problems

  • Device Dislodged or Dislocated1
  • Device Endoleak1
  • Difficult or Delayed Separation1
  • Fracture1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • Clinical Endoleak1
  • Perforation of Vessels1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJun 17, 2026Device Dislodged or Dislocated

    THE FOLLOWING WAS REPORTED TO GORE: DURING A THORACOABDOMINAL ENDOVASCULAR (TAMBE) PROCEDURE ON (B)(6) 2026, GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS (VBX DEVICES) WERE IMPLANTED IN THE VISCERAL ARTERIES AS BRANCH DEVICES. ACCESS WAS MADE FROM THE GROIN AREA. IT WAS REPORTED THAT A 7FR COOK ANSEL SHEATH WAS PLACED INSIDE AN 8FR TOURGUIDE¿ STEERABLE SHEATH. AS THE 8X59 VBX DEVICE WAS ADVANCED INTO THE SUPERIOR MESENTERIC ARTERY, THE VBX DEVICE DISLODGED FROM THE CATHETER. THE PHYSICIAN WAS ABLE TO INSERT A SECONDARY BALLOON THAT WAS SLIGHTLY INFLATED INTO THE VBX DEVICE. USING THE BALLOON THE VBX DEVICE WAS PLACED AT THE INTENDED LOCATION AND DEPLOYED WITH NO ISSUES. USING THE SAME SHEATHS, A 7X29 VBX DEVICE WAS IMPLANTED DISTALLY. NEXT, THE 6X39 VBX DEVICE WAS BEING ADVANCED INTO THE LEFT RENAL ARTERY. HOWEVER, THE VBX DEVICE DISLODGED FROM THE CATHETER. USING THE SAME TECHNIQUE, A SECONDARY BALLOON WAS USED TO PUSH THE VBX DEVICE INTO PLACE AND IT WAS DEPLOYED WITH NO ISSUES. IT WAS REPORTED BOTH OF THE DISLODGED VBX DEVICES HAD PROBLEMS TRACKING UP AND OVER A TRANSFEMORAL APPROACH IN THE TAMBE DEVICE. IT WAS REPORTED THE PATIENT IS DOING WELL FOLLOWING THE PROCEDURE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 25540677 ↗
  • InjuryNov 20, 2025Device Endoleak; Device Endoleak

    THE FOLLOWING INFORMATION WAS REPORTED THROUGH THE AAA 24-01 TAMBE POST APPROVAL STUDY: ON (B)(6) 2025, THE PATIENT UNDERWENT ENDOVASCULAR TREATMENT OF A THORACOABDOMINAL ANEURYSM USING A GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS (TAMBE) DEVICE SYSTEM AND GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS (VBX DEVICE). ON (B)(6) 2025, THE PATIENT UNDERWENT ENDOVASCULAR TREATMENT OF A TYPE IC ENDOLEAK. A GORE® VIABAHN® ENDOPROSTHESIS WAS IMPLANTED TO TREAT THE ENDOLEAK AS THE LEFT RENAL ARTERY STENT EXTENSION.

    Patient problems: Clinical Endoleak

    MAUDE report 23606525 ↗
  • InjuryMar 15, 2025Difficult or Delayed Separation; Difficult or Delayed Separation

    ON (B)(6) 2025, A PATIENT UNDERWENT TREATMENT FOR A SPLENIC ARTERY ANEURYSM. ACCESS WAS FROM THE ARTERY VIA THE RADIAL APPROACH FROM THE WRIST. A 6FR TERUMO RADIAL SHEATH WAS USED TO ADVANCE A REDUCED PROFILE GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS (VBX DEVICE/STENT) OVER A SUPRA CORE GUIDEWIRE. IT WAS REPORTED THAT DURING THE PROCEDURE, PHYSICIAN ENCOUNTERED DIFFICULTY DEPLOYING A 6MM X 39MM VBX DEVICE/STENT DUE TO THE PATIENT'S TORTUOUS ANATOMY. THE PHYSICIAN-MAINTAINED PRESSURE AT THE NOMINAL LEVEL FOR ABOUT 20 SECONDS BEFORE SLOWLY DEFLATING THE BALLOON. WHEN PUSHED FORWARD, THE BALLOON SEPARATED FROM THE VBX DEVICE/STENT. THE CATHETER WAS THEN PULLED BACK WITH SOME FORCE, CAUSING THE SHEATH TO ADVANCE FORWARD. INITIALLY, IMAGING APPEARED NORMAL; HOWEVER, A SECOND IMAGE FROM A DIFFERENT ANGLE REVEALED BLEEDING BETWEEN THE VBX DEVICE/STENT AND THE SHEATH, SUGGESTING A POSSIBLE PERFORATION. THE PHYSICIAN SUSPECTED THE BLEEDING MAY HAVE BEEN CAUSED BY THE FORCEFUL RETRACTION OF THE DELIVERY CATHETER DUE TO PATIENT'S TORTUOUS ANATOMY. REPORTEDLY, THE STICTION HAD ALREADY BEEN RESOLVED PRIOR TO THE PERFORATION. AFTER THE DELIVERY CATHETER WITH BALLOON WERE REMOVED, TWO

    Patient problems: Perforation of Vessels

    MAUDE report 21613116 ↗
  • InjuryJan 16, 2025Fracture; Fracture

    THE FOLLOWING WAS REPORTED TO GORE: ON (B)(6) 2025, A PATIENT WAS TREATMENT FOR A STENOTIC OCCLUSION IN THE SUPERIOR MESENTERIC ARTERY. ACCESS WAS MADE FROM THE RIGHT GROIN. A 7FR TOURGUIDE SHEATH WAS USED TO ADVANCE THE GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS (VBX DEVICE) OVER A BENTSON WIRE TO THE INTENDED TREATMENT SITE. THE VBX DEVICE DEPLOYED FINE AND WAS POST DILATED USING AN 8 X 2 BALLOON (UNSPECIFIED BRAND). ON (B)(6) 2025, THE PHYSICIAN REPORTED THE POST-PROCEDURE IMAGES APPEARED TO INDICATE A VBX STENT FRACTURE. THEREFORE, A NEW VBX DEVICE WAS IMPLANTED THAT SAME DAY TO RELINE THE EXISTING VBX DEVICE. THE PATIENT IS RECOVERING WELL.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21173032 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P160021. One submission often covers many models, so check the product and lot details in each record.

  • Z-0077-2022 · Sep 7, 2021 · Open, Classified
    Heparin, GORE VIABAHN VBX, BALLOON EXPANDABLE ENDOPROTHESIS, REF BXAL085902E, 8 MM X 59 MM 8 Fr, LARGE BALLOON EXPANDLBE, Nominal Stent Diameter 8 mm, Max Post-Dilated Stent Diame

Other Iliac covered stent, arterial devices

All Iliac covered stent, arterial devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page